Scholar Rock Holding Corporation
NASDAQ:SRRK
Overview | Financials
Company Name | Scholar Rock Holding Corporation |
Symbol | SRRK |
Currency | USD |
Price | 44.32 |
Market Cap | 4,149,012,368 |
Dividend Yield | 0% |
52-week-range | 6.76 - 46.185 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jay T. Backstrom M.D., M.P.H. |
Website | https://scholarrock.com |
An error occurred while fetching data.
About Scholar Rock Holding Corporation
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD